171 related articles for article (PubMed ID: 3300761)
1. A comparison of the incidence of the myelodysplastic syndrome and acute myeloid leukaemia following melphalan and cyclophosphamide treatment for myelomatosis. A report to the Medical Research Council's working party on leukaemia in adults.
Cuzick J; Erskine S; Edelman D; Galton DA
Br J Cancer; 1987 May; 55(5):523-9. PubMed ID: 3300761
[TBL] [Abstract][Full Text] [Related]
2. [Acute myelogenous leukemia in myelomatosis].
Tidsskr Nor Laegeforen; 1977 Feb; 97(4):175-7. PubMed ID: 265102
[No Abstract] [Full Text] [Related]
3. Long-term survival in myelomatosis. A report to the MRC working party on leukaemia in adults.
Buckman R; Cuzick J; Galton DA
Br J Haematol; 1982 Dec; 52(4):589-99. PubMed ID: 6958312
[TBL] [Abstract][Full Text] [Related]
4. Treatment comparisons in the third MRC myelomatosis trial. Medical Research Council's Working Party on Leukaemia in Adults.
Br J Cancer; 1980 Dec; 42(6):823-30. PubMed ID: 7006664
[TBL] [Abstract][Full Text] [Related]
5. Report on the second myelomatosis trial after five years of follow-up. Medical Research Council's Working Party on Leukaemia in Adults.
Br J Cancer; 1980 Dec; 42(6):813-22. PubMed ID: 7006663
[TBL] [Abstract][Full Text] [Related]
6. Cytogenetic abnormalities in acute leukemia complicating melphalan-treated multiple myeloma.
Rödjer S; Swolin B; Weinfeld A; Westin J
Cancer Genet Cytogenet; 1990 Aug; 48(1):67-73. PubMed ID: 2372790
[TBL] [Abstract][Full Text] [Related]
7. [Impacts of new agents for multiple myeloma on development of secondary myelodysplastic syndrome and acute myeloid leukemia].
Hamano A; Shingaki S; Abe Y; Miyazaki K; Sekine R; Nakagawa Y; Tsukada N; Hattori Y; Suzuki K
Rinsho Ketsueki; 2014 Apr; 55(4):428-35. PubMed ID: 24850453
[TBL] [Abstract][Full Text] [Related]
8. Objective evaluation of the role of vincristine in induction and maintenance therapy for myelomatosis. Medical Research Council Working Party on Leukaemia in Adults.
MacLennan IC; Cusick J
Br J Cancer; 1985 Aug; 52(2):153-8. PubMed ID: 3896288
[TBL] [Abstract][Full Text] [Related]
9. Three cases of multiple myeloma developing into melphalan-related chronic myelomonocytic leukemia.
Ueki K; Sato S; Tamura J; Sawamura M; Murakami H; Naruse T; Tsuchiya J
J Med; 1991; 22(3):157-61. PubMed ID: 1770323
[TBL] [Abstract][Full Text] [Related]
10. [Results of combined treatment of advanced forms of multiple myeloma with vincristine, melphalan, cyclophosphamide and prednisone (VMCP) and with vincristine, doxorubicin, cyclophosphamide and prednisone (VDCP)].
Robak T; Krykowski E; Płuzańska A; Olszańska-Skorek T; Urbańska-Ryś H; Polkowska-Kulesza E; Błasińska-Morawiec M; Mazurowa A
Pol Tyg Lek; 1983 Apr; 38(16):481-4. PubMed ID: 6579509
[No Abstract] [Full Text] [Related]
11. Leukaemia on myeloma.
Webb JA; Bateman CJ; Davies JD
Br Med J; 1971 Oct; 4(5781):231. PubMed ID: 5286613
[No Abstract] [Full Text] [Related]
12. Acute leukemia and cytogenetic abnormalities complicating melphalan treatment of primary systemic amyloidosis.
Gertz MA; Kyle RA
Arch Intern Med; 1990 Mar; 150(3):629-33. PubMed ID: 2310282
[TBL] [Abstract][Full Text] [Related]
13. Therapy-related myelodysplastic syndrome/acute leukemia after multiple myeloma in the era of novel agents.
Gertz MA; Terpos E; Dispenzieri A; Kumar S; Shah RA; Orlowski R; Kastritis E; Dimopoulos MA; Shah J
Leuk Lymphoma; 2015 Jun; 56(6):1723-6. PubMed ID: 25284489
[TBL] [Abstract][Full Text] [Related]
14. Comparison of melphalan and prednisone with vincristine, carmustine, melphalan, cyclophosphamide, and prednisone in the treatment of multiple myeloma: results of Eastern Cooperative Oncology Group Study E2479.
Oken MM; Harrington DP; Abramson N; Kyle RA; Knospe W; Glick JH
Cancer; 1997 Apr; 79(8):1561-7. PubMed ID: 9118039
[TBL] [Abstract][Full Text] [Related]
15. Alkylating agents as leukemogens in multiple myeloma.
Karchmer RK; Amare M; Larsen WE; Mallouk AG; Caldwell GG
Cancer; 1974 Apr; 33(4):1103-7. PubMed ID: 4522494
[No Abstract] [Full Text] [Related]
16. Corticosteroid is not beneficial in multiple-drug combination chemotherapy for multiple myeloma. Finnish Leukaemia Group.
Palva IP; Ala-Harja K; Almqvist A; Elonen E; Hallman H; Hänninen A; Ilvonen M; Isomaa B; Jouppila J; Järvenpää E
Eur J Haematol; 1993 Aug; 51(2):98-101. PubMed ID: 8370425
[TBL] [Abstract][Full Text] [Related]
17. [Multiple myeloma preceding myelodysplastic syndrome with eosinophilia and der (1;7)].
Matano S; Kobayashi K; Nakamura S; Yoshida T
Rinsho Ketsueki; 1994 Nov; 35(11):1310-4. PubMed ID: 7823398
[TBL] [Abstract][Full Text] [Related]
18. A progress report on the Medical Research Council's therapeutic trial in myelomatosis.
Galton DA; Peto R
Br J Haematol; 1968 Sep; 15(3):319-20. PubMed ID: 5696221
[No Abstract] [Full Text] [Related]
19. Myelomatosis: comparison of melphalan and cyclophosphamide therapy.
Br Med J; 1971 Mar; 1(5750):640-1. PubMed ID: 4926948
[TBL] [Abstract][Full Text] [Related]
20. [Multiple myeloma and terminal acute myeloid leukaemia (author's transl)].
Labedzki L; Fuchs HJ; Grips KH
Dtsch Med Wochenschr; 1976 Jan; 101(4):108-11. PubMed ID: 812690
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
